UTI Small Cap Fund · Regular · Growth
NAV
₹26.6387
as of 18 Nov 2026
Expense Ratio
2.01%
AUM
₹5,348 Cr
Lumpsum returns (CAGR)
- 1Y
- +1.73%
- 3Y
- +10.43%
- 5Y
- +11.72%
- Since Inception
- +3.88%
SIP returns (XIRR)
- 1Y
- +8.20%
- 3Y
- +6.40%
- 5Y
- +11.54%
- Since Inception
- +6.17%
Returns calculated from 06 May 2002 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 5 years (Nov 2021 – Nov 2026)
A ₹5,000 monthly SIP for the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹3,95,650 today — ₹3,00,000 invested, 11.3% XIRR.
₹3,00,000
Invested
₹3,95,650
Value today
11.3%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,73,331 today (11.6% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2021 would still hold ₹13,37,658.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹3,95,650 in this fund vs ₹4,21,641 in the benchmark — underperformance of ₹25,991.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Nov 2021 – Nov 2026) (4 Jun 2024) would be ₹1,26,905 today (1.27×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.03
Sharpe Ratio
—
Alpha
—
Beta
-0.02
Sortino
15.09%
Std Dev
-18.94%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology11.44%
- Capital Markets6.81%
- Industrial Products6.66%
- Healthcare Services6.16%
- Chemicals & Petrochemicals5.85%
- Banks5.63%
- Electrical Equipment5.24%
- Auto Components4.91%
- Consumer Durables4.40%
- Finance4.38%
- Commercial Services & Supplies3.96%
- Retailing3.64%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Small Cap Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with UTI Small Cap Fund - Regular Plan - IDCW (Payout)
- 1Acutaas Chemicals Limited3.15%
- 2Navin Fluorine International L2.61%
- 3Karur Vysya Bank Ltd.2.61%
- 4Great Eastern Shipping Co. Ltd1.93%
- 5Marksans Pharma Ltd.1.92%
- 6Pnb Housing Finance Ltd.1.77%
- 7Ujjivan Small Finance Bank Ltd1.69%
- 8Td Power Systems Ltd.1.65%
- 9Affle 3i Limited1.63%
- 10Tips Music Limited1.63%
What this fund does
UTI Small Cap Fund · Regular · Growth aims to generate long-term capital appreciation by investing in small-cap companies — ranked 251st and below by market capitalisation. Small-cap funds carry wider price swings than large-cap and mid-cap funds.
About This Fund
UTI Small Cap Fund · Regular · Growth is a Small Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 25 years. It manages assets worth ₹5,348 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty Smallcap 250 TRI. The current expense ratio is 2.01%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •Small-cap stocks can swing sharply in both directions — the category is built for money that can stay invested for years
- •SIP investors who can benefit from rupee cost averaging during market fluctuations